Your request to link to MMDB for Cyclooxygenase
MMDB Description | |
---|---|
14210 | Crystal Structure Analysis of the Complex Lfa-1 (Cd11a) I- Domain Lovastatin at 2.6 Å Resolution |
12344 | Cryo-em Structure of Human Rhinovirus 16 (Hrv16) Complexed With a Two-domain Fragment of ITS Cellular Receptor, Intercellular Adhesion Molecule-1 (D1d2-icam-1). Implications for Virus-receptor Interactions. Alpha Carbons Only |
12345 | Cryo-em Structure of Human Rhinovirus 14 (Hrv14) Complexed With a Two-domain Fragment of ITS Cellular Receptor, Intercellular Adhesion Molecule-1 (D1d2-icam-1). Implications for Virus-receptor Interactions. Alpha Carbons Only |
11463 | D1d2-icam-1 Fully Glycosylated, Variation of D1-d2 Interdomain Angle in Different Crystal Structures |
12821 | NMR Solution Structure of the Inserted Domain of Human Leukocyte Function Associated Antigen-1 |
56405 | Structure of the Two Amino-terminal Domains of Human Intercellular Adhesion Molecule-1, Icam-1 |
8008 | The Crystal Structure for the N-terminal Two Domains of Icam-1 |
50114 | Cd11a I-domain With Bound Mn++ |
21755 | Crystal Structure of the Intermediate Affinity AL I Domain M |
21774 | Crystal Structure of Alphal I Domain in Complex With Icam-1 |
21775 | Crystal Structure of High Affinity Alphal I Domain With Ligand Mimetic Crystal Contact |
21776 | Crystal Structure of High Affinity Alphal I Domain in the Absence of Ligand or Metal |
27259 | The Crystal Structure of Icam-1 D3-d5 Fragment |
26905 | An Allosteric Inhibitor of Lfa-1 Bound to ITS I-domain |
32239 | Structural Basis of Icam Recognition by Integrin Alpahlbeta2 Revealed in the Complex Structure of Binding Domains of Icam-3 and Alphalbeta2 at 1.65 a |
29803 | X-ray Structure of Lfa-1 I-domain in Complex With Lfa703 at 2.2a Resolution |
29804 | X-ray Structure of Lfa-1 I-domain in Complex With Lfa878 at 2.1a Resolution |
35501 | X-ray Structure of Lfa-1 I-domain Bound to a 1,4-diazepane- 2,5-dione Inhibitor at 1.8a Resolution |
34295 | Cryo-em Structure of Human Coxsackievirus A21 Complexed With Five Domain Icam-1kilifi |
52284 | Cd11a I-domain Without Bound Cation |
52285 | Cd11a I-domain With Bound Magnesium Ion |
52286 | Cd11a I-domain With Bound Magnesium Ion |
43402 | Cd11a (Lfa1) I-domain Complexed With Bms-587101 AKA 5-[(5s, 9r)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4- Dioxo-1,3,7-triazaspiro [4.4]non-7-yl]methyl]-3- Thiophenecarboxylicacid |
68334 | Solution Structure of Integrin Alpha L |
45177 | Cd11a (Lfa1) I-domain Complexed With 7a-[(4-cyanophenyl) Methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7a-tetrahydro- 1h-pyrrolo[1,2-a]pyrrole-7-carbonitrile |
59211 | Structural Plasticity in Igsf Domain 4 of Icam-1 Mediates Cell Surface Dimerization |
66151 | Crystal Structure of Icam-5 in Complex With AL I Domain |
66152 | Lfa-1 I Domain Bound to Inhibitors |
66153 | Lfa-1 I Domain Bound to Inhibitors |
66221 | Lfa-1 I Domain Bound to Inhibitors |
70831 | Crystal Structure the FAB Fragment of Efalizumab in Complex With Lfa-1 I Domain, Form I |
70832 | Crystal Structure the FAB Fragment of Efalizumab in Complex With Lfa-1 I Domain, Form II |
73828 | Crystal Structure of Wild Type Lfa1 I Domain |
73829 | Crystal Structure of Wild Type Lfa1 I Domain Complexed With Isoflurane |
76869 | Crystal Structure of Intermediate Affinity I Domain of Integrin Lfa-1 With the FAB Fragment of ITS Antibody Al-57 |
82054 | Cd11a I-domain Complexed With 6-((5s,9r)-9-(4-cyanophenyl)-3 Dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7- Triazaspiro[4.4]n Nicotinic Acid |